Tag:
IoGen
Latest Headlines
Latest Headlines
Symbollon warns of trouble after Phase III failure
Symbollon Pharmaceuticals says its pain therapy IoGen flunked a late stage trial for moderate to severe cyclic pain associated with fibrocystic breast disease. And the results could well threaten
